TRAVIS ROEDER: Open Payments
NPI 1396446829 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$196 in 10 payments from 8 companies in 2025. Trend: 2023 $271 · 2024 $318 · 2025 $196
Food & beverage: $196
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $58 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: NEFFY, QULIPTA, NP Thyroid 60, Ozempic, Rybelsus, REXULTI, Veozah, Wegovy.
Industry payments across TX — which companies pay providers there.
